Skip to main content

An Economic Gamble

What does society get for the billions it spends on science?

Written byKerry Grens
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00

In 1930, the US Congress gave a group of scientists and administrators $750,000 to start a new agency, the National Institute of Health. Over time, "Institute" became "Institutes," and appropriations grew. In 1938, the NIH received $464,000 for research - roughly equivalent to $6.8 billion in today's dollars. This year, NIH will spend approximately $29 billion on research. The National Science Foundation, founded in 1950, will spend another $6 billion.

Each year, appropriations are passed around before ending up at a final figure. For the 2006 NIH budget, the Federation of American Societies for Experimental Biology (FASEB) requested $30.07 billion. President George Bush requested $28.8 billion, the House approved $28.5 billion, while the Senate wanted to appropriate $29.4 billion. Ultimately, NIH received $28.6 billion.

What formula directs such tweaking? With hundreds of billions of dollars at their disposal for discretionary spending, and numerous other projects to fund - including education and healthcare - how do presidents, lawmakers, and their staff settle on what goes where?

For a recent example, I looked to the California Institute for Regenerative Medicine, now run by Robert Klein, chair of CIRM's Independent Citizens' Oversight Committee. Several years ago, Klein was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays